Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19
Status:
Recruiting
Trial end date:
2020-06-10
Target enrollment:
Participant gender:
Summary
As the world faces COVID-19, the search for effective treatments against the disease and its
complications has turned its gaze to drugs that are classically used in other infectious
diseases. Some drugs are being examined for the recent evidence on its effects on viral
replication and inflammation, one is Azithromycin, used to treat a wide variety of bacterial
infections, Ivermectin, an anti-parasitic drug and the other is Cholecalciferol to increase
serum concentration of 25-hydroxyvitamin D.
Phase:
N/A
Details
Lead Sponsor:
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado